Trailing-twelve-month (TTM) revenue is $98.34 Million with a year-over-year growth of +140.58%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $12,880,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $19,967,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-12 |
| Q1 FY2026Period ended 2026-03-31 | $20,746,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-29 |
| Q2 FY2026Period ended 2026-06-30 | $44,745,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $98,338,000 |
Current P/S: $1,853,146,386 market capitalization ÷ $98,338,000 TTM revenue = 18.84x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:20:11.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $44.74M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:20:31.988Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Collaboration Revenue, Other | $8M | N/A | N/A | N/A | N/A | N/A |
| Collaboration Revenue, Related Party | $39M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20252025-12-31 · USD |
|---|---|
| Non-US | $5M |
| UNITED STATES | $49M |
$98.34M
$98.34 Million
+140.58%
vs. $40.88M a year ago (TTM)
+4.54%
5 Year compound annual growth rate
1 Year
+140.58%
3 Year
+69.61%
5 Year
+4.54%
10 Year
+7.01%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $54.03M | +$17.53M | +48.03% |
| 2024 | $36.50M | +$9.68M | +36.07% |
| 2023 | $26.82M | +$12.58M | +88.36% |
| 2022 | $14.24M | ($103.67M) | (87.92%) |
| 2019 | $117.91M | +$23.52M | +24.92% |
| 2018 |
TTM Growth
+140.58%
3-Year CAGR
+69.61%
5-Year CAGR
+4.54%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:20:31.988Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| N/A |
| N/A |
| N/A |
| N/A |
| Commercialization Activity | $3M | $4M | N/A | N/A | N/A | N/A |
|---|
| Committee Participation | $0 | $0 | N/A | N/A | N/A | N/A |
|---|
| Development Activities | $0 | $0 | N/A | N/A | N/A | N/A |
|---|
| Product | $60M | $121M | $12M | $27M | $36M | $54M |
|---|
| Research Services | $36M | $64M | N/A | N/A | N/A | N/A |
|---|
| Royalty | $11M | $10M | $3M | $0 | N/A | N/A |
|---|
| $94.39M |
| +$51.38M |
| +119.45% |
| 2017 | $43.01M | ($26.88M) | (38.46%) |
| 2016 | $69.89M | +$10.77M | +18.22% |
| 2015 | $59.12M | ($6.24M) | (9.55%) |
| 2014 | $65.36M | +$39.81M | +155.82% |
